BiOM Ankle Prosthetic Named as Finalist in the 2012 Medical Design Excellence Awards

Worcester, MA – April 26, 2012

Cogmedix today announced that it is a named supplier to the BiOM Ankle Prosthetic, a device chosen as a finalist in the rehabilitation and assistive-technology product category of the 2012 Medical Design Excellence Awards (MDEA) competition, submitted by iWalk Inc. ( Bedford, MA ). Cogmedix is an ISO 13485 certified and FDA compliant medical device con tract manufacturer and has been the contract manufacturer for iWalk’s BiOM Ankle since its production release.

Cogmedix is a wholly owned subsidiary of Coghlin Companies, a fourth generation privately owned contract engineering and manufacturing company located in central Massachusetts.

Medical Design and Diagnostic Industry (MD+DI), the global MedTech authority providing the medical device industry with the latest news, information, and in-depth analysis, announced the finalists, and their suppliers, in the 2012 MDEA competition in its April issue published this week.

Sponsored by MD+DI and organized by UBM Canon, the MDEA competition is the premier awards program for the medical technology community. It recognizes the achievements of medical device manufacturers, their suppliers, and the many people behind the scenes — engineers, scientists, designers, and clinicians — who are responsible for the grou ndbreaking innovations that are changing the face of healthcare. MDEA – finalist and winning entries excel in the areas of product innovation, design and engineering achievement, end-user benefit, and cost-effectiveness in manufacturing and healthcare delivery.

A comprehensive review of the entries was performed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering, clinical practice, diagnostics, human factors, industrial design, manufacturing, and medicine. Entries are evaluated on the basis of their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and change traditional medical attitudes or practices, features that provide enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives. The 2012 MDEA Jury selected 41 finalists in 10 medical product categories.

“It’s an honor to contribute to the success of such a wonderful product. We are proud that our contributions to the BiOM Ankle have been recognized,” said Matt Giza, Vice President and General Manager of Cogmedix. “We are confident that our continued attention to compliance and quality will help iWalk continue changing lives.”

Winning products will be announced at the MDEA Presentation Ceremony held on Wednesday, May 23, 20, 2012 at 4:30 pm during a cocktail reception inside the Philadelphia Marriott Downtown hotel. The ceremony is held in conjunction with the MD&M East Event ( ) at the adjacent Pennsylvania Convention Center, May 22 – 24, 2012.

During the MDEA Presentation Ceremony on May 23, 2012:

  • The 2012 MDEA finalists and their suppliers will be honored for their innovative contributions to the medical device industry.
  • Up to one Bronze, one Silver, and one Gold – winning product will be announced in each category.
  • One Gold-winning product will be awarded “Best-in-Show”.
  • The NCIIA will announce the winners of the 2012 BMEidea, a biomedical engineering competition for university students.
  • Famed inventor Dr. Thomas Fogarty will be presented with the prestigious MDEA Lifetime Achievement Award.

About Medical Design Excellence Awards

The MDEA program is presented by UBM Canon, the global advanced manufacturing and MedTech authority, and by Medical Device and Diagnostic Industry (MD+DI), the industry’s central source for late breaking news, information, and business intelligence. The 2012 Medical Design Excellence Awards are sponsored by Platinum Sponsor: Phillips-Medisize and Silver Sponsor: Teleflex Medical OEM.

For more information on the Medical Design Excellence Awards , visit , or e-mail

About Cogmedix

Cogmedix is a US-based, FDA QSR compliant, ISO 13485 certified contract manufacturer for medical and clinical devices. A subsidiary of Coghlin Companies Inc., Cogmedix focuses on the production of Class I and Class II medical and clinical devices for the critical care, home healthcare, emergency room, and industrial laboratories markets. Cogmedix focuses on aligning itself with companies seeking a compliant, conscientious, cost effective, domestic manufacturing resource to assist them with volume turnkey manufacturing. For more information about Cogmedix, please visit

About Coghlin Companies, Inc.

Coghlin Companies, Inc. is a privately held company specializing in helping companies cost effectively improve their time-to-market. Based in Worcester, Massachusetts, Coghlin Companies spans four generations representing more than 126 years of manufacturing experience and leadership. Subsidiaries include: Columbia Tech, which provides turnkey manufacturing services to a diverse customer base, including OEMs in the bio-science, semiconductor, LED, medical device, green energy technology, data storage, and automation systems and controls industries; DCI Engineering, an engineering design and pre-production support services company; and Cogmedix, an FDA compliant and ISO 13485 certified medical subassembly and finished medical device contract manufacturer. For more information, please visit or sign up for the Coghlin Companies e-Newsletter at /newsletter-signup/.